• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press
VASRO GmbH

Sector Insights: Analyzing Trends in Pharma, Biotech, Tech, and Energy

  • May 23, 2025
  • Energy, Pharma & Biotech, Tech
Analyze investment opportunities in pharma, biotech, tech, and energy sectors. Discover trends driving growth, innovation, and sustainable returns.
Continue Reading
VASRO GmbH

Galaxy Digital achieves Nasdaq listing, marking a new era in growth strategy

  • May 22, 2025
  • Unkategorisiert
Galaxy Digital's Nasdaq listing boosts its U.S. visibility, attracting investors and solidifying its growth strategy in cryptocurrency and artificial intelligence.
Continue Reading
VASRO GmbH

Why Global Investors Are Turning to Asia in 2025

  • May 21, 2025
  • Unkategorisiert
Global investors are drawn to Asia in 2025 due to its economic growth, expanding consumer markets, and opportunities in technology, sustainability, and trade.
Continue Reading
VASRO GmbH

Charles River Laboratories Experiences Significant Stock Surge

  • May 20, 2025
  • Pharma & Biotech
Charles River Laboratories' stock surge reflects strong financial results, governance changes, and strategic growth initiatives, boosting investor confidence.
Continue Reading
VASRO GmbH

Top 10 Equity Analysis Techniques Used by Leading Research Firms

  • May 19, 2025
  • Unkategorisiert
Discover the top 10 equity analysis techniques used by leading research firms to evaluate stocks, mitigate risks, and optimize investment strategies.
Continue Reading
VASRO GmbH

Pharma and Biotech Innovations Driving Strategic Industry Trends in 2025

  • May 16, 2025
  • Pharma & Biotech
Pharma and biotech innovations in 2025 are driving AI-powered drug discovery, precision medicine, and global trends, reshaping healthcare and R&D strategies.
Continue Reading
VASRO GmbH

Energy Innovations Driving Strategic Industry Trends in 2025

  • May 15, 2025
  • Energy
Energy innovations in 2025 are driving industry trends, boosting sustainability, efficiency, and growth through renewables, storage, and green hydrogen.
Continue Reading
VASRO GmbH

How Equity Analysis Enhances Tech Stock Valuation

  • May 14, 2025
  • Tech
Equity analysis bridges market trends and intrinsic value, offering data-driven insights to accurately value tech stocks and navigate market volatility.
Continue Reading
VASRO GmbH

Top Trends Driving Solar Energy Investments in 2025

  • May 13, 2025
  • Energy, Tech
Solar energy investment in 2025: top trends and opportunities include AI, bifacial panels, energy storage, and policy incentives driving clean energy growth.
Continue Reading
VASRO GmbH

Pharma 2025: Investing in a Tech-Driven Future

  • May 12, 2025
  • Pharma & Biotech, Tech
Explore how AI, gene editing, and digital tools are driving a tech-driven future in pharma, reshaping drug discovery, clinical trials, and manufacturing.
Continue Reading

Posts pagination

Previous 1 … 19 20 21 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.